Clinical Trial Update: EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece

View source ↗

Summary

This document provides an update on the EVOLVE study, evaluating real-world use of tezepelumab for asthma in Greece. The trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: ACTIVE_NOT_RECRUITING